MAP1LC3A and necrotizing enterocolitis: In the small intestine of NEC protocol exposed animals without intestinal necrosis, Beclin 1 and LC3 immunoreactivity and Beclin 1 and LC3II protein levels were decreased and p62 immunoreactivity and protein levels were increased in EPO treated animals compared to non-EPO treated animals [194].